BioAtla's Unattributed Round

BioAtla raised a round of funding on January 12, 2016. Investors include Global BIO Impact Fund.

BioAtla is a global biotechnology company developing novel monoclonal antibody and other protein therapeutic products utilizing our proprietary technologies for product design and development. The com…

Articles about BioAtla's Unattributed Round: